Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
about
Maximizing the clinical utility of antimüllerian hormone testing in women's healthAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsImpact of cancer therapies on ovarian reserveFollicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort studyThe physiology and clinical utility of anti-Mullerian hormone in women.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersAnti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery.Serum antimüllerian hormone in healthy premenopausal women.BRCA1 germline mutations may be associated with reduced ovarian reserve.Does hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study.What affects functional ovarian reserve, thyroid function or thyroid autoimmunity?How Much Does AMH Really Vary in Normal Women?Peripubertal changes in circulating antimüllerian hormone levels in girls.Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery.What does anti-Müllerian hormone tell you about ovarian function?Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.Ovarian reserve screening: a scientific and ethical analysis.Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.Administration of Oral Contraceptives Could Alleviate Age-Related Fertility Decline Possibly by Preventing Ovarian Damage in a Mouse Model.Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion.Anti-Müllerian hormone, the holy grail for fertility counselling in the general population?
P2860
Q26822937-1C78635D-9B55-4F79-9C1D-FFBD2E45ABD8Q28239980-9C77B056-E1FB-4B72-91D6-BE1E53917DAFQ28384958-10756AC1-BEB6-45CD-AF26-7B6A2A2D39E6Q28730415-3834A5DC-7660-464A-B189-AF51B7AA3E05Q34398233-C52A93B3-C3B9-4AEC-8DA8-C5FC7E9A80FAQ35108269-88EEDD86-A075-416B-A0B2-A222F0EB90BBQ35158333-0F451577-15D2-460D-96D1-F1BA1C702390Q35185385-B304CE50-629A-4BF8-AA57-4088FAF63B9EQ35213292-502FB28B-24E7-46BB-8F00-CED2C93601F6Q36797854-1EE6D425-4AF8-421D-9E74-3A2ECC92776AQ36886970-D97DC5AA-AFB4-4E99-867A-EE95AF92AD1AQ37367598-165FBCE1-BC80-449D-8C49-3C1A4F6B77C4Q37531205-AD46B1BA-9982-40F5-A7A8-138EEFE390DAQ38785823-E691767F-981F-4B4F-A5A2-B14FD7B9B6D0Q39581951-9982342D-9ABA-498B-8D44-909ABC8108DEQ39612287-964CDFDF-60C1-406C-9C20-066EB57C389EQ39822162-3119B628-40E1-46EE-85A3-DD1850C54DE0Q40603713-975E0762-9D51-4486-9827-E06217B96BBEQ41601823-63522622-908A-4F5F-9822-52E42CA6E1B8Q46366566-2F8EE0E7-3245-4ADB-A0FC-1CF0A8FF1E7AQ47565519-B5082965-B8C0-4FB2-B269-C53818E48A17Q47881670-DD9F0A62-C69B-4523-A951-5468233D142DQ47953132-15A158E7-7C3B-4A1D-ACFF-A35431DF393AQ48522417-AF6939D9-A2DD-4A06-89F0-9664C9BA50E2Q48602762-2E1E2642-47D9-4B42-90D6-61EFEBCD18E9Q50857392-83F1899C-9364-435F-93EE-0947A7D084F1Q50952822-518D963A-028B-42B0-9C7E-24689225F24EQ53365992-78743979-5762-420F-B230-F27B9C7A35A4
P2860
Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Comparison of ovarian function ...... tural early follicular phases.
@en
Comparison of ovarian function ...... tural early follicular phases.
@nl
type
label
Comparison of ovarian function ...... tural early follicular phases.
@en
Comparison of ovarian function ...... tural early follicular phases.
@nl
prefLabel
Comparison of ovarian function ...... tural early follicular phases.
@en
Comparison of ovarian function ...... tural early follicular phases.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of ovarian function ...... tural early follicular phases.
@en
P2093
A Overbeek
C B Lambalk
E van Dulmen-den Broeder
F E van Leeuwen
G J Kaspers
J W R Twisk
M H van den Berg
P2860
P304
P356
10.1093/HUMREP/DEQ071
P407
P577
2010-03-27T00:00:00Z